Heart Failure Management for Nurse Practitioners, Physician Assistants and Primary Care Providers
Mayo School of Continuous Professional DevelopmentHeart Failure Management for Nurse Practitioners, Physician Assistants and Primary Care Providers Update 2013 March 17-19, 2013 Omni La Mansión del Rio San Antonio, Texas • Clinical Syndrome of Heart Failure • Foundations of Treatment for Heart Failure • Heart Failure Across the Stages • Advanced Heart Failure Management • End of Life Management Course Directors: Jean A. Wagner, M.S., C.N.P. Barry L. Karon, M.D. REGISTER ONLINE NOW!http://www.mayo.edu/cme/cardiovascular-diseases-2013r998
COURSE DESCRIPTIONHeart failure is a devastating disease that causes debilitating symptoms and excessmortality. It affects more than 5 million persons in this country, with over 700,000new cases diagnosed each year. It remains the most common discharge diagnosisfor hospitalized adults and accounts for 12 to 15 million office visits annually.Despite our best efforts, more than one-third of patients with heart failure arere-hospitalized within weeks of hospital discharge. Certainly as our populationages, the number of patients afflicted with this disease will grow. The economicburden now exceeds 10 billion dollars, and is forecasted to grow.It is essential that heart failure is recognized promptly and proven therapies areapplied to manage this chronic disease. Nurse practitioners, physician assistants andprimary care providers play a pivotal role in the care of these patients. Using acase-based approach, this course will enhance the attendees’ confidence in caring forthese challenging patients.COURSE LEARNING OBJECTIVESUpon conclusion of this program, participants should be able to:• Recognize the clinical syndrome of heart failure and who is at risk;• Articulate typical diagnostic testing essential for diagnosis and management of heart failure;• Incorporate appropriate pharmacologic and non-pharmacologic strategies for patients across the spectrum of heart failure;• Describe when referral for advanced heart failure therapies is indicated; and,• Describe treatment strategies to manage symptoms when conventional therapies have been exhausted.Attendance at this Mayo course does not indicate nor guarantee competence orproficiency in the performance of any procedures which may be discussed or taughtin this course.INTENDED AUDIENCEThis course is appropriate for nurse practitioners, physician assistants, registerednurses, cardiologists, and primary care providers interested in an update on heartfailure.CREDITCollege of Medicine, Mayo Clinic, is accredited by the Accreditation Council forContinuing Medical Education to provide continuing medical education forphysicians.College of Medicine, Mayo Clinic, designates this live activity for a maximum of15.75 AMA PRA Category 1 Credits™. Physicians should claim only the creditcommensurate with the extent of their participation in the activity.Optional Session:College of Medicine, Mayo Clinic, designates this live activity for a maximum of1.50 AMA PRA Category 1 Credits™. Physicians should claim only the creditcommensurate with the extent of their participation in the activity.Other Health Care ProfessionalsA certificate of attendance will be provided to other health care professionals forrequesting credits in accordance with state nursing boards, specialty societies, orother professional associations.
DATE AND LOCATIONHeart Failure Management: Update 2013 will be held March 17 – 19, 2013 at the Omni LaMansión del Rio in San Antonio, Texas. The program will be held in the IberianBallroom, Second Floor.LODGING ACCOMMODATIONSGuest rooms have been reserved for attendees and their guests with special courserates at the Omni La Mansión del Rio. In order to receive the special rate,reservations must be made before the room block is filled or before the expirationdate of February 12, 2013, whichever comes first. Reservations will be takenfollowing this date based on space and rate availability. Please identify yourself as aparticipant of the Mayo Heart Failure Program when making your reservation toensure the group rate.Omni La Mansión del Rio $209 single/double112 College StreetSan Antonio, Texas 78205Phone: 1-800-The-Omni (1-800-843-6664) Lodging arrangements are the sole responsibility of the individual registrant.Mayo School of CPD is not responsible for expenses incurred by an individual whois not confirmed and for whom space is not available at the meeting. Costs incurredby the registrant such as airline or hotel fees or penalties are the responsibility of theregistrant.PARKINGValet and self-parking is available. The cost for parking is not included in theregistration fee.FACULTYCourse DirectorsBarry L. Karon, M.D.Jean A. Wagner, M.S., C.N.P.Mayo FacultyNandan S. Anavekar, M.B., B.Ch. Wayne L. Miller, M.D., Ph.D.Christopher J. Arendt, Pharm.D., R.Ph. Jill J. Nagel, P.A.-C.Dalene M. Bott Kitslaar, M.S., C.N.P. Pankaj Shah, M.D.Robert P. Frantz, M.D. Keith M. Swetz, M.D.Janell G. Grazzini Frantz, M.S., C.N.P. Amy W. Williams, M.D.FACULTY DISCLOSUREAs a provider accredited by ACCME, College of Medicine, Mayo Clinic (Mayo Schoolof Continuous Professional Development) must ensure balance, independence,objectivity and scientific rigor in its educational activities. Course director(s),planning committee, faculty, and all others who are in a position to control thecontent of this educational activity are required to disclose all relevant financialrelationships with any commercial interest related to the subject matter of theeducational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticalsor instruments discussed in their presentation. Disclosure of this information willbe published in course materials so those participants in the activity may formulatetheir own judgments regarding the presentation.
PROGRAMSunday, March 17, 20137:00 a.m. Registration & Continental Breakfast7:50 a.m. Opening Remarks and Pre TestThe Clinical Syndrome of Heart FailureModerator: Barry L. Karon, MD.8:00 a.m. Is This Heart Failure? Making the Clinical Diagnosis Jean Wagner, M.S., C.N.P.8:25 a.m. Questions8:30 a.m. The Echo Report: Deciphering the Jibberish Barry L. Karon, M.D.8:55 a.m. Questions9:00 a.m. Diagnostic Imaging in Heart Failure – Which One, When? Nuclear, CT, MRI, PET Nandan S. Anavekar, M.B., B.Ch.9:25 a.m. Questions9:30 a.m. BNP for Diagnosis, Risk Stratification, and Guiding Therapy in Heart Failure Barry L. Karon, M.D.9:55 a.m. Questions10:00 a.m. Refreshment Break10:20 a.m. Exercise Stress Tests: When and Why to Use Them Grace Lin, M.D.10:45 a.m. Questions10:50 a.m. Etiology and Clinical Characteristics of Dilated Cardiomyopathy Janell G. Grazzini Frantz, M.S., C.N.P.11:15 a.m. Questions11:20 a.m. The Next Generation of Heart Failure Patients – The Cardiometabolic Syndrome Pankaj Shah, M.D.11:45 a.m. Questions11:50 a.m. Hypertension Management Along the Continuum of Heart Failure Stages Amy W. Williams, M.D.12:15 p.m. Questions12:20 p.m. Lunch1:20 p.m. Practice Pearls for Patients with Heart Failure and Diabetes Pankaj Shah, M.D.1:45 p.m. Questions
1:50 p.m. Heart Failure with Preserved Ejection Fraction Barry L. Karon, M.D.2:15 p.m. Questions2:20 p.m. Non Pharmacologic Management in Heart Failure Janell Grazzini Frantz, M.S., C.N.P.2:45 p.m. Questions2:50 p.m. So Your Patient Has Heart Failure: Discussing the HF Trajectory with Your Patient Jean A. Wagner, M.S., C.N.P.3:15 p.m. Questions3:20 p.m. AdjournMonday, March 18, 20137:30 a.m. Continental BreakfastFoundations of Heart Failure TreatmentModerator: Jean A.Wagner, M.S., C.N.P.8:00 a.m. ACE Inhibitors and Beta Blockers – Practice Pearls Beyond the Guidelines Janell Grazzini Frantz, M.S., C.N.P.8:25 a.m. Questions8:30 a.m. The Other Heart Failure Drugs: Digoxin, Spironolactone, Eplerenone Wayne L. Miller, M.D., Ph.D.8:55 a.m. Questions9:00 a.m. Outpatient Fluid Management Beyond Furosemide Jean A. Wagner, M.S., C.N.P.9:25 a.m. Questions9:30 a.m. Approaching the Hospitalized Patient with Heart Failure Grace Lin, M.D.9:55 a.m. Questions10:00 a.m. Refreshment Break10:20 a.m. Devices in Heart Failure: Prevention, Treatment, and Monitoring Jill J. Nagel, P.A.-C.10:45 a.m. Questions10:50 a.m. Polypharmacy in the Geriatric Heart Failure Patient – Watch Out! Christopher J. Arendt, Pharm.D., R.Ph.11:15 a.m. Questions11:20 a.m. Anticoagulation Pearls for Heart Failure Patients Dalene M. Bott Kitslaar, M.S., C.N.P.11:45 a.m. Questions11:50 a.m. Atrial Fibrillation in Heart Failure Patients Jill J. Nagel, P.A.-C.12:15 p.m. Questions12:20 pm Lunch
1:20 p.m. Left-Sided Valvular Heart Disease: Medications or Surgery? Grace Lin, M.D.1:45 p.m. Questions1:50 p.m. Treating Heart Failure in the Setting of Advanced Kidney Disease Amy W. Williams, M.D.2:15 p.m. Questions2:20 p.m. Update in Pulmonary Hypertension and Right Heart Failure Robert P. Frantz, M.D.2:45 p.m. Questions2:50 p.m. Common Mistakes Made in Heart Failure Management – Case Studies Moderator: Barry L. Karon, M.D. Panel: Drs. Lin, Williams, Wagner, Arendt, and Anavekar3:30 p.m. AdjournTuesday, March 19, 20137:30 a.m. Continental Breakfast7:50 a.m. Post TestAdvanced Heart FailureModerator: Jean A. Wagner, M.S., C.N.P.8:00 a.m. Discussing Prognosis, Palliative Care, and Hospice Keith M. Swetz, M.D.8:25 a.m. Questions8:30 a.m. When to Consider Chronic Outpatient Inotrope Therapy Wayne L. Miller, M.D., Ph.D.8:55 a.m. Questions9:00 a.m. Managing Symptoms at End of Life – Dyspnea, Anxiety, Pain Keith M. Swetz, M.D.9:25 a.m. Questions9:30 a.m. Cardiac Replacement: LVADs – How They Work, Who Needs Them, and What Should I Know If My Patient Has One Robert P. Frantz, M.D.10:00 a.m. Refreshment Break10:20 a.m. Cardiac Replacement: Transplant – When to Refer and What Should I Know If My Patient Has Had a Transplant Robert P. Frantz, M.D.10:45 a.m. Questions10:50 a.m. Illustrative Cases in Advanced Heart Failure Moderator: Jean A. Wagner, M.S., C.N.P. Panel: Drs. Swetz, Miller, Frantz, and Ms. Grazzini Frantz11:45 a.m. AdjournOptional Session – Please sign-up when registering1:30 – 3:00 p.m. Echo Basic Tutorial Barry L. Karon, M.D.
REGISTRATION Register online:http://www.mayo.edu/cme/cardiovascular-diseases-2013R998Registration Fee:Full Registration Fee(MD, PhD, PharmD) $675Reduced Registration Fee(Fellow/Resident, RN, Emeritus) $600Mayo Clinic Division of Cardiology has recently implemented an onlineconference registration system. If this is your first time using the online system,you will need to create a profile and login account.The system will step you through the profile and login process. An email addressis required upon registration. Please keep the login information for futureuse in completing the course evaluation and obtaining your cme record ofattendance.The registration fee includes tuition, electronic syllabus, continental breakfastsand break refreshments. Although it is not Mayo School of ContinuousProfessional Development (CPD) policy to limit the number of registrants for acourse, conference room facilities may necessitate closing of enrollment;therefore, early registration is advised. A letter of confirmation will be e-mailedupon receipt of payment. Please present the confirmation letter when checkingin at the meeting registration desk.For additional information, contact:Mayo Cardiovascular CME Office200 First Street SW – Gonda 6-472Rochester, MN 55905E-mail: firstname.lastname@example.orgPhone: 800-283-6296Fax: 507-538-0146Website: http://www.mayo.edu/cme/cardiovascular-diseases-2013R998CANCELLATION POLICYIf you cancel your participation in this course, your registration fee, less a $75administrative fee, will be refunded when written notification is received by MayoCardiovascular CME office by March 3, 2013 (fax#: 507-538-0146). No refundswill be made on or after March 3, 2013. Canceled registrations are non-transferable.Mayo School of CPD reserves the right to cancel or postpone any course due tounforeseen circumstances. In the unlikely event Mayo School of CPD mustcancel or postpone this course, Mayo School of CPD will refund the registrationfee, but is not responsible for any related costs, charges, or expenses toparticipants, including fees assessed by airline/travel/lodging agencies.